[1st experiences with a new hormonal contraceptive agent Gravistat-Jenapharm].
D000152:Acne Vulgaris / Q000139:chemically induced; D001777:Blood Coagulation / Q000187:drug effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004341:Drug Evaluation; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009644:Norgestrel / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D009644:Norgestrel; D004997:Ethinyl Estradiol
Erste Erfahrungen mit einem neuen hormonalen Kontrazeptivum: Gravistat-Jenapharm